Concepedia

Peppi Prasit

PP

28

Publications

1.4K

Citations

22

H-Index

1993

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Merck Canada Inc. (Canada)

Amplyx Pharmaceuticals (United States)

United States Military Academy

Incept (United States)

Peppi Prasit is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicine, and drug discovery.

Top concepts

Publications per year

1993–2024

28

Publications

28

A novel, orally active LPA <sub>1</sub> receptor antagonist inhibits lung fibrosis in the mouse bleomycin model

J. S. Swaney, Charles W. Chapman, LD Correa et al. · British Journal of Pharmacology · 2010 · 257 citations · Full text

Novel, Nonpeptidic Cyanamides as Potent and Reversible Inhibitors of Human Cathepsins K and L

Jean‐Pierre Falgueyret, Renata M. Oballa, Osamu Okamoto et al. · Journal of Medicinal Chemistry · 2000 · 127 citations · Full text

, , +18

Pharmacokinetic and Pharmacodynamic Characterization of an Oral Lysophosphatidic Acid Type 1 Receptor-Selective Antagonist

J. S. Swaney, Charles W. Chapman, Lucia Correa et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 126 citations

Design and Synthesis of Tri-Ring P<sub>3</sub> Benzamide-Containing Aminonitriles as Potent, Selective, Orally Effective Inhibitors of Cathepsin K

James T. Palmer, Clifford Bryant, Dan-Xiong Wang et al. · Journal of Medicinal Chemistry · 2005 · 94 citations · Full text

, , +18

A Novel Class of Nonpeptidic Biaryl Inhibitors of Human Cathepsin K

Joël Robichaud, Renata M. Oballa, Peppi Prasit et al. · Journal of Medicinal Chemistry · 2003 · 82 citations · Full text

, , +18

Rows per page

1–5 of 28